entertainment -WSS

entertainment

author：hotspot 2025-10-02 18:50:10 - browse：4788

Illustration of a human hand beneath a projection of digital files to visualize humans' role in AI technology — Adobe

Developers of artificial intelligence models slowly making their way into medicine have long parried ethical concerns with assertions that clinical staff must review tech’s suggestions before they are acted on. That “human in the loop” is meant to be a backstop preventing potential medical errors conjured up by a flawed algorithm from harming patients.

And yet, industry experts warn that there’s no standard way to keep humans in the loop, giving technology vendors significant latitude to market their AI-powered products as helpful professional tools rather than as autonomous decision-makers.

Health record giant Epic is piloting a generative AI feature that drafts responses to patients’ email queries, but clinical staff must review the suggestions before they are sent out, the company has said. A flurry of AI-guided ambient documentation startups can rapidly transcribe and summarize patient visits and populate patients’ medical charts, but they require doctors and nurses to OK the generated entries first. Products predicting health risks — like overdose or sepsis — show up as flags in medical record software, and it’s up to clinicians to act on it.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Humana’s losses in Medicare Advantage tank its stock

explore

WSS

Cytokinetics CEO stresses company can launch heart drug on its own

Investment in vaccine development is lagging, report finds

With measles on the rise, a personal story of a devastating disease

Syphilis numbers in the United States reach record heights

Reconstructing family trees of blood cells may help predict disease

Humana’s losses in Medicare Advantage tank its stock

entertainment

entertainment

explore

Novavax promises a turnaround & Lilly roils the obesity market

NVIDIA and Google execs on the future of AI and drug discovery

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Cytokinetics CEO stresses company can launch heart drug on its own

Peter Hotez and the public health issue of online harassment

New clues to why women have higher risk of autoimmune disorders

New air purifier tech could be key to improving indoor air quality

Boston competes with Raleigh

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

hotspot

Solving academic medical centers' existential crisis

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Medicare Advantage insurers face 0.2% cut to 2025 payments

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Boston competes with Raleigh

hotspot

explore

focus

knowledge